The China Transcatheter Aortic Valve Implantation (TAVI) Market is expected to grow by US$ 990 million during 2020-2026, progressing at a CAGR of 52.8% during the forecast period.

This industry report offers market estimates and forecasts of the China market, followed by a detailed analysis of the eligible patients. The China market data on transcatheter aortic valve implantation (TAVI) can be segmented by eligible patients: SAVR (surgical aortic valve replacement) high risk, SAVR (surgical aortic valve replacement) inoperable, SAVR (surgical aortic valve replacement) intermediate risk, and SAVR (surgical aortic valve replacement) low risk.

The study provides historical market data (2016-2019) and forecasts from 2020 till 2026. The market size and estimations are provided in terms of revenue (million USD) considering 2019 as base year and market forecast will be given from 2020 to 2026.

The data-centric report focuses on market trends, status and outlook for segments, and future growth. With comprehensive coverage of the market across different market segments the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

Get a detailed picture of the China Transcatheter Aortic Valve Implantation (TAVI) Market
Identify segments/areas to invest in over the forecast period in the China Transcatheter Aortic Valve Implantation (TAVI) Market
Understand the competitive environment, the markets leading players